Navigation Links
SurgiLance Safety Lancet Part of Major HIV Testing Initiative in Sub-Saharan Africa

NORCROSS, Ga., April 17 /PRNewswire/ -- The SurgiLance safety lancet, an industry-leading medical safety product manufactured by MediPurpose, has been selected for inclusion in an HIV kit distributed throughout Africa by Nigerian-based Bundi International Diagnostics. Long established in the Americas and Europe, SurgiLance safety lancets are now part of a major testing initiative designed to stem the tide of HIV/AIDS on the African continent.

A critical component of the fight against AIDS, HIV testing initiatives identify those at risk for developing AIDS and make early intervention and treatment possible. Last year alone, more than 1.7 million adults and children became infected with HIV in Sub-Saharan Africa. In this region most devastated by the AIDS epidemic, an astonishing 1.6 million people lost their lives to AIDS in 2007.

"This new relationship with Bundi International Diagnostics underscores our commitment to those front-line medical professionals committed to global health initiatives like HIV/AIDS prevention," says MediPurpose CEO Patrick Yi. "A growing number of test kit manufacturers have chosen the SurgiLance safety lancet for their point-of-care test kits which are used both in medical facilities and in the field," added Randy Prather, MediPurpose VP for Sales and Marketing. "In addition to their use in HIV test kits, SurgiLance safety lancets can be used to test for Hepatitis and Chagas and are commonly used in glucose and cholesterol testing."

Manufactured in Nigeria, Bundi HIV test kits are widely used in state and federal hospitals, non-governmental organizations, clinics, voluntary counseling and testing centers. The Bundi kit contains all items necessary to perform HIV testing. The test kit can be refrigerated or stored at room temperature, making it a convenient choice even for poorly-equipped laboratories and field locations without lab facilities or electricity.

"The SurgiLance safety lancet is a critical component of the Bundi Rapid HIV-1/2 Test Kit and sets us apart from other HIV test kits," says Bundi president Robert Udeagha. "The SurgiLance safety lancet allows consistent depth of penetration, provides optimal blood flow in mere seconds, delivers a quality blood sample and is virtually pain-free for patients undergoing HIV testing. Best of all," says Udeagha, "the inclusion of SurgiLance safety lancets completely eliminates the dangers associated with accidental needle stick, which is one means of HIV transmission."

About MediPurpose

MediPurpose designs, manufactures and markets innovative healthcare solutions valued by its customers. The company is known for introducing quality safety medical devices that protect healthcare professionals from sharps injury. Founded in 1999, the company achieved rapid success with its SurgiLance safety lancet, quickly becoming one of the top leaders in the US safety lancet market and establishing solid distribution channels worldwide.

As a globally recognized innovator, MediPurpose has developed a menu of services to assist inventors and growing medical device companies successfully design, patent, manufacture and sell their products. MediPurpose maintains offices in the US, Singapore, the UK, France and Spain.

For more information on MediPurpose, visit .

SOURCE MediPurpose
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Cardiac Safety Study of Stinger S-200 Published
2. Micromet Presents Safety and Efficacy Data from Primate Studies With Two New BiTE Antibodies Developed for Treatment of Leukaemia and Melanoma
3. VIA Pharmaceuticals Announces Updated DSMB Safety Results for VIA-2291 Ongoing Phase 2 Clinical Program
4. EnVivo Pharmaceuticals Announces Initiation of Clinical Safety and Biomarker Study of Alpha-7 Nicotinic Agonist, EVP-6124, in Patients with Schizophrenia
5. Final Data From the Bioheart Seismic Trial Suggest Safety, Efficacy of Autologous Stem-Cell Therapy for Treating Congestive Heart Failure
6. Final Data From the SEISMIC Trial Suggest Safety, Efficacy of Autologous Stem- Cell Therapy for Treating Congestive Heart Failure
7. Independent Data Safety Monitoring Board Recommends Continuation of Sangarts Pivotal Phase III Trials of Hemospan(R) Following Second Interim Review
8. HUYA Bioscience Intl Announces Clinical Trial Milestones in China for Promising New Anti-Arrhythmic Compound; Data Supports Desirable Safety Profile
9. FluoroPharma Announces Positive Phase I Safety Results for CardioPET(TM), Coronary Artery Disease (CAD) Imaging Tracer for Positron Emission Tomography (PET)
10. DATATRAK and COResearch to Collaborate on Six Cardiac Safety Projects
11. Media Statement: MHA Keystone Center for Patient Safety & Quality OHRP Ruling
Post Your Comments:
(Date:6/23/2016)... ITASCA, Ill. , June 23, 2016  In a startling ... states are failing their residents by lacking a comprehensive, proven plan ... , a definitive ranking of how states are tackling the ... rating to only four states – Kentucky , ... and Vermont . Of the 28 failing states, ...
(Date:6/23/2016)... , June 23, 2016 Research and ... Devices Medical Market Analysis 2016 - Forecast to 2022" ... The report contains up to date financial data derived ... Assessment of major trends with potential impact on the market ... of market segmentation which comprises of sub markets, regional and ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... to their offering. The ... commercial environment for MedImmune to enter. The US ageing population ... to drive considerable growth for effective anti-influenza medications. The introduction ... considerably, but development is still in its infancy. ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding ... of its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. ... James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/25/2016)... ... 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s ... setting the bar too high can result in disappointment, perhaps even self-loathing. However, those ... goal. , Research from reveals that behind the tendency to ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Those who ... with these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, ... Marne, Michigan, has released tools for healthy coping following a traumatic event. , Trauma ...
(Date:6/24/2016)... ... 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out of ... verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. ... throw rocks at my other children and say he was going to kill them. ...
Breaking Medicine News(10 mins):